Petros Pharmaceuticals, Inc. (PTPI)
NASDAQ: PTPI · Real-Time Price · USD
0.335
+0.007 (2.10%)
At close: Nov 5, 2024, 4:00 PM
0.345
+0.010 (3.02%)
After-hours: Nov 5, 2024, 4:23 PM EST
Petros Pharmaceuticals Employees
Petros Pharmaceuticals had 21 employees as of December 31, 2023. The number of employees decreased by 3 or -12.50% compared to the previous year.
Employees
21
Change (1Y)
-3
Growth (1Y)
-12.50%
Revenue / Employee
$196,223
Profits / Employee
-$983,068
Market Cap
3.35M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 21 | -3 | -12.50% |
Dec 31, 2022 | 24 | 0 | - |
Dec 31, 2021 | 24 | -3 | -11.11% |
Dec 31, 2020 | 27 | -18 | -40.00% |
Dec 31, 2019 | 45 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Venus Concept | 304 |
iSpecimen | 53 |
Biodexa Pharmaceuticals | 21 |
Palisade Bio | 9 |
TNF Pharmaceuticals | 6 |
Oragenics | 5 |
Tharimmune | 3 |
Alaunos Therapeutics | 1 |
PTPI News
- 5 weeks ago - NextTrip Prepares Compass.tv for Soft Launch, Signs New Content Creators - Accesswire
- 7 weeks ago - Petros Pharmaceuticals Executes Successful Initial Test for App Comprehension as Part of FDA Pathway for Over-the-Counter Access for STENDRA(R) (avanafil) - Accesswire
- 2 months ago - Petros Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference - Accesswire
- 3 months ago - NextTrip Introduces Group Booking Technology Platform to Streamline and Simplify Travel for Groups - Accesswire
- 3 months ago - Petros Pharmaceuticals' Pivotal Statistically Significant Self Selection Study Shows Stronger Results with Proprietary Technology Application as Part of FDA Pathway for Over-the-Counter Access for STENDRA(R) (avanafil) - Accesswire
- 3 months ago - NextTrip, Inc. Receives Nasdaq Notification Regarding Late 10-Q Filing and Continued Listing Requirements - Accesswire
- 3 months ago - NextTrip Taps Dooya Media Group To Launch Compass.TV - Accesswire
- 4 months ago - Petros Pharmaceuticals' STENDRA(R) (avanafil) Pivotal Consumer Self-Selection Study for Over-the-Counter Access Demonstrates Statistical Significance - Accesswire